A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the safety and efficacy of investigational therapeutics for the treatment Of COVID-19 In hospitalized adults
Principal Investigator(s)
Email for information
Funded by
HJF
Research Start Date
Status
Inactive
The primary objectives of this study are to evaluate the clinical efficacy of different investigational therapeutics relative to the control arm in adults hospitalized with COVID-19.
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.